Merck increased list prices on Keytruda, Gardasil in November

Merck & Co. raised its U.S. list prices on five drugs in November, including its top-selling cancer immunotherapy, Keytruda, and its top-selling vaccine, Gardasil, a company spokesperson confirmed Thursday to BioPharma Dive.